The clinical features and potential mechanisms of cognitive disorders in peripheral autoimmune and inflammatory diseases

[1]  R. Sharma,et al.  Cognitive dysfunction in ulcerative colitis patients in remission and its comparison with patients with irritable bowel syndrome and healthy controls , 2021, Indian Journal of Gastroenterology.

[2]  K. Karalis,et al.  Hippocampal neural stem cells and microglia response to experimental inflammatory bowel disease (IBD) , 2020, Molecular Psychiatry.

[3]  J. Božić,et al.  Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease , 2019, Scientific Reports.

[4]  Yanchuan Shi,et al.  The role of inflammation and endoplasmic reticulum stress in obesity-related cognitive impairment. , 2019, Life sciences.

[5]  Jing Liu,et al.  The Impact of Vitamin D on Cognitive Dysfunction in Mice with Systemic Lupus Erythematosus , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[6]  Yun Huang,et al.  Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: results from a prospective cross-sectional study , 2019, BMC Endocrine Disorders.

[7]  R. Boostani,et al.  Subtypes of Antiphospholipid Antibodies in Neurologic Disorders: An Observational Study. , 2018, Current rheumatology reviews.

[8]  M. Triggiani,et al.  Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review. , 2019, Journal of Alzheimer's disease : JAD.

[9]  R. McIntyre,et al.  Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder , 2018, Front. Psychiatry.

[10]  R. Cantello,et al.  Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy , 2018, Front. Neurol..

[11]  J. Woo,et al.  From Gut to Brain: Alteration in Inflammation Markers in the Brain of Dextran Sodium Sulfate-induced Colitis Model Mice , 2018, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[12]  A. Maszczyk,et al.  Brain-derived neurotrophic factor, insulin like growth factor-1 and inflammatory cytokine responses to continuous and intermittent exercise in patients with type 1 diabetes. , 2018, Diabetes research and clinical practice.

[13]  G. Silva,et al.  Neurologic manifestations of antiphospholipid syndrome , 2018, Lupus.

[14]  G. Valesini,et al.  Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study , 2018, PloS one.

[15]  G. Ruiz-Irastorza,et al.  Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis , 2018, Journal of the International Neuropsychological Society.

[16]  R. Grassi‐Oliveira,et al.  Autoantibodies against myelin sheath and S100β are associated with cognitive dysfunction in patients with rheumatoid arthritis , 2017, Clinical Rheumatology.

[17]  P. Gibson,et al.  Cognitive impairment in Crohn’s disease is associated with systemic inflammation, symptom burden and sleep disturbance , 2017, United European gastroenterology journal.

[18]  L. Lerman,et al.  Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics. , 2017, Journal of the American College of Cardiology.

[19]  K. Blennow,et al.  Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype , 2017, Neurobiology of Aging.

[20]  M. van Buchem,et al.  Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement , 2017, Rheumatology.

[21]  L. Trouw,et al.  Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus , 2016, Lupus.

[22]  S. Appenzeller,et al.  Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome , 2016, Current Rheumatology Reports.

[23]  Melvyn W B Zhang,et al.  A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. , 2016, Autoimmunity reviews.

[24]  A. Uluğ,et al.  Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody–Positive Patients , 2016, Arthritis care & research.

[25]  J. Furness.  Integrated Neural and Endocrine Control of Gastrointestinal Function. , 2016, Advances in experimental medicine and biology.

[26]  K. Kothur,et al.  CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review. , 2016, Cytokine.

[27]  J. Baek,et al.  Brain-derived Neurotrophic Factor Is Associated with Cognitive Impairment in Elderly Korean Individuals , 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

[28]  P. Huerta,et al.  Integrative neuroscience approach to neuropsychiatric lupus , 2015, Immunologic Research.

[29]  K. Michelsen,et al.  Chronic intestinal inflammation alters hippocampal neurogenesis , 2015, Journal of Neuroinflammation.

[30]  M. Goldacre,et al.  Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998–2011: a retrospective national record linkage cohort study , 2015, Diabetologia.

[31]  N. Inestrosa,et al.  Anti–Ribosomal P Protein Autoantibodies From Patients With Neuropsychiatric Lupus Impair Memory in Mice , 2015, Arthritis & rheumatology.

[32]  J. Chapman,et al.  IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome. , 2014, Journal of autoimmunity.

[33]  I. Amit,et al.  Aging-induced type I interferon response at the choroid plexus negatively affects brain function , 2014, Science.

[34]  V. Villanacci,et al.  Neurological disorders and inflammatory bowel diseases. , 2014, World journal of gastroenterology.

[35]  D. Matsuzawa,et al.  Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia , 2014, Neuroscience Letters.

[36]  J. Hanly.  Diagnosis and management of neuropsychiatric SLE , 2014, Nature Reviews Rheumatology.

[37]  R. Schmidt,et al.  Anticardiolipin antibodies are associated with cognitive dysfunction in stroke‐free individuals , 2014, European Journal of Neurology.

[38]  S. Devaraj,et al.  Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. , 2014, The Journal of clinical endocrinology and metabolism.

[39]  Ryuichi Morishita,et al.  Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors , 2013, Front. Aging Neurosci..

[40]  S. Krilis,et al.  The pathogenesis of the antiphospholipid syndrome. , 2013, The New England journal of medicine.

[41]  M. Maes,et al.  A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior , 2013, BMC Medicine.

[42]  Michael Maes,et al.  Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway , 2013, Molecular Neurobiology.

[43]  A. Ergul,et al.  Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes , 2013, PloS one.

[44]  H. Okamoto,et al.  IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells. , 2013, Arthritis and rheumatism.

[45]  C. Ayata,et al.  Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury. , 2013, The Journal of clinical investigation.

[46]  S. West.  Chapter 29 – Clinical Aspects of the Nervous System , 2013 .

[47]  C. Pariante,et al.  Inflammation and depression. , 2013, Current topics in behavioral neurosciences.

[48]  G. Morris,et al.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome , 2013, Metabolic Brain Disease.

[49]  R. Ho,et al.  Dysfunctional cortico-basal ganglia-thalamic circuit and altered hippocampal-amygdala activity on cognitive set-shifting in non-neuropsychiatric systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[50]  N. Sheibani,et al.  Pericytes Regulate Vascular Basement Membrane Remodeling and Govern Neutrophil Extravasation during Inflammation , 2012, PloS one.

[51]  B. Engelhardt,et al.  The anatomical and cellular basis of immune surveillance in the central nervous system , 2012, Nature Reviews Immunology.

[52]  M. Wallhagen,et al.  Cognitive impairment in persons with rheumatoid arthritis , 2012, Arthritis care & research.

[53]  Martin Klein,et al.  Resting-State Brain Networks in Type 1 Diabetic Patients With and Without Microangiopathy and Their Relation to Cognitive Functions and Disease Variables , 2012, Diabetes.

[54]  R. Scrivo,et al.  Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage , 2012, PloS one.

[55]  F. Barkhof,et al.  Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions , 2012, Diabetologia.

[56]  R. Sperling,et al.  Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[57]  H. Soininen,et al.  Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. , 2012, Journal of Alzheimer's disease : JAD.

[58]  L. Caniatti,et al.  Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. , 2012, Rheumatology.

[59]  L. Pogach,et al.  Risk of Hypoglycemia in Older Veterans with Dementia and Cognitive Impairment: Implications for Practice and Policy , 2011, Journal of the American Geriatrics Society.

[60]  B. Zlokovic,et al.  Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.

[61]  T. Brismar,et al.  Decreased cortical connectivity and information flow in type 1 diabetes , 2011, Clinical Neurophysiology.

[62]  Emeran A. Mayer,et al.  Gut feelings: the emerging biology of gut–brain communication , 2011, Nature Reviews Neuroscience.

[63]  R. Dale,et al.  Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies , 2011, Developmental medicine and child neurology.

[64]  R. Dantzer,et al.  Inflammation-associated depression: From serotonin to kynurenine , 2011, Psychoneuroendocrinology.

[65]  M. Mogi,et al.  Neurovascular coupling in cognitive impairment associated with diabetes mellitus. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[66]  J. Connolly,et al.  Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus , 2011, Science Translational Medicine.

[67]  S. Hamed,et al.  Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis , 2011, Clinical Rheumatology.

[68]  R. Grassi‐Oliveira,et al.  Interleukin-6 and verbal memory in recurrent major depressive disorder. , 2011, Neuro endocrinology letters.

[69]  Derek K. Jones,et al.  Diffusion tensor imaging. , 2011, Methods in molecular biology.

[70]  L. Rajasekhar,et al.  O7 Severity of cognitive impairment in SLE is related to disease activity: single center case control study , 2010 .

[71]  P. Gorelick.  Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials , 2010, Annals of the New York Academy of Sciences.

[72]  G. Tsokos,et al.  Interleukin-17-producing T cells in lupus , 2010, Current opinion in rheumatology.

[73]  Oberdan Leo,et al.  Key concepts in immunology. , 2010, Vaccine.

[74]  A. Sima.  Encephalopathies: the emerging diabetic complications , 2010, Acta Diabetologica.

[75]  J. Kipnis,et al.  Regulation of learning and memory by meningeal immunity: a key role for IL-4 , 2010, The Journal of experimental medicine.

[76]  Y. Shoenfeld,et al.  Neurological manifestations of antiphospholipid syndrome , 2010, European journal of clinical investigation.

[77]  M. Barbhaiya,et al.  Moderate versus high-titer persistently anticardiolipin antibody positive patients: Are they clinically different and does high-titer anti-β2-glycoprotein-I antibody positivity offer additional predictive information? , 2010, Lupus.

[78]  W. Banks,et al.  The blood–brain barrier and immune function and dysfunction , 2010, Neurobiology of Disease.

[79]  G. Gurtner,et al.  HIF-1α dysfunction in diabetes , 2010 .

[80]  Glinda S Cooper,et al.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. , 2009, Journal of autoimmunity.

[81]  C. Stam,et al.  Functional Brain Connectivity and Neurocognitive Functioning in Patients With Long-Standing Type 1 Diabetes With and Without Microvascular Complications , 2009, Diabetes.

[82]  T. Möller,et al.  Potent Induction of IFN-α and Chemokines by Autoantibodies in the Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus1 , 2009, The Journal of Immunology.

[83]  B. Mueller,et al.  Diffusion Tensor Imaging Identifies Deficits in White Matter Microstructure in Subjects With Type 1 Diabetes That Correlate With Reduced Neurocognitive Function , 2008, Diabetes.

[84]  L. Stein,et al.  Low Plasma Brain-Derived Neurotrophic Factor and Childhood Physical Neglect Are Associated with Verbal Memory Impairment in Major Depression—A Preliminary Report , 2008, Biological Psychiatry.

[85]  S. Rantapää-Dahlqvist,et al.  BDNF in RA: Downregulated in plasma following anti-TNF treatment but no correlation with inflammatory parameters , 2008, Clinical Rheumatology.

[86]  D. Tanné,et al.  Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome , 2008, Neurobiology of Disease.

[87]  I. Deary,et al.  Cognition and diabetes: a lifespan perspective , 2008, The Lancet Neurology.

[88]  R. Dantzer,et al.  Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .

[89]  H. Moutsopoulos,et al.  Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. , 2006, Archives of internal medicine.

[90]  D. Leys,et al.  Diabetes mellitus and dementia. , 2006, Diabetes & metabolism.

[91]  C. Ryan.  Diabetes and brain damage: more (or less) than meets the eye? , 2006, Diabetologia.

[92]  J. Haorah,et al.  Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions , 2006, Journal of Neuroimmune Pharmacology.

[93]  J. Przybylski,et al.  The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise. , 2006, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[94]  F. Barkhof,et al.  Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy , 2006, Diabetologia.

[95]  In Kyoon Lyoo,et al.  Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. , 2006, Diabetes.

[96]  O T Wolf,et al.  Hippocampal volume and cognitive performance in long‐standing Type 1 diabetic patients without macrovascular complications , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[97]  S. Khoshbin,et al.  Lateralized cognitive dysfunction in patients with systemic lupus erythematosus , 2005, Lupus.

[98]  L. Velloso,et al.  Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. , 2005, Endocrinology.

[99]  I. Deary,et al.  Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. , 2005, Diabetes care.

[100]  R. Keep,et al.  Monocyte Chemoattractant Protein-1 Regulation of Blood–Brain Barrier Permeability , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[101]  Geert Jan Biessels,et al.  The effects of type 1 diabetes on cognitive performance: a meta-analysis. , 2005, Diabetes care.

[102]  P. Williams,et al.  Predictors of cognitive dysfunction in patients with systemic lupus erythematosus , 2005, Neurology.

[103]  S. Davies,et al.  Molecular mechanisms of cerebrospinal fluid production , 2004, Neuroscience.

[104]  J. Mikdashi,et al.  Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. , 2004, Rheumatology.

[105]  Genhong Cheng,et al.  The Art of War: Innate and adaptive immune responses , 2003, Cellular and Molecular Life Sciences CMLS.

[106]  T. Orchard,et al.  Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications , 2003, Diabetologia.

[107]  G. Hughes,et al.  Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. , 2003, The Journal of rheumatology.

[108]  L. Provinciali,et al.  Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. , 2002, Clinical and experimental rheumatology.

[109]  M. Bendayan,et al.  Morpho-functional studies of the blood-brain barrier in streptozotocin-induced diabetic rats , 2002, Diabetologia.

[110]  G. Gronseth,et al.  Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions , 2002, Neurology.

[111]  R. de Caterina,et al.  Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses , 2002, Circulation.

[112]  M. Ueno,et al.  Blood–Brain Barrier Disruption in White Matter Lesions in a Rat Model of Chronic Cerebral Hypoperfusion , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[113]  A. Auvinen,et al.  Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. , 2001, Arthritis and rheumatism.

[114]  L. Vignolo,et al.  Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations , 2001, Journal of the Neurological Sciences.

[115]  C. Janeway,et al.  Innate immunity. , 2000, The New England journal of medicine.

[116]  M. Weinand,et al.  Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. , 1999, The American journal of pathology.

[117]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[118]  L. Rapport,et al.  Neuropsychological deficits associated with antiphospholipid antibodies. , 1999, Journal of clinical and experimental neuropsychology.

[119]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[120]  D. Isenberg,et al.  A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[121]  J. Chapman,et al.  Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes , 1999, Lupus.

[122]  M. Tohyama,et al.  Involvement of Bcl‐2 Family and Caspase‐3‐Like Protease in NO‐Mediated Neuronal Apoptosis , 1998 .

[123]  D. Karussis,et al.  A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity? , 1998, Annals of neurology.

[124]  S. Levine,et al.  Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events , 1998, Neurology.

[125]  W. Grassi,et al.  The clinical features of rheumatoid arthritis. , 1998, European journal of radiology.

[126]  A. Korczyn,et al.  Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. , 1997, The Journal of clinical investigation.

[127]  M. Hartmann,et al.  Myeloid-related Protein (MRP) 8 and MRP14, Calcium-binding Proteins of the S100 Family, Are Secreted by Activated Monocytes via a Novel, Tubulin-dependent Pathway* , 1997, The Journal of Biological Chemistry.

[128]  I. Wilkinson,et al.  Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[129]  C. Heizmann,et al.  The S100 family of EF-hand calcium-binding proteins: functions and pathology. , 1996, Trends in biochemical sciences.

[130]  D. Zimmer,et al.  The S100 protein family: History, function, and expression , 1995, Brain Research Bulletin.

[131]  J. Camp.  Physical Examination of the Musculoskeletal System , 1989 .

[132]  A. Drash,et al.  Cognitive deficits in adolescents who developed diabetes early in life. , 1985, Pediatrics.